Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

76.84
-0.3400-0.44%
Post-market: 76.880.0400+0.05%19:30 EDT
Volume:1.52M
Turnover:117.29M
Market Cap:10.68B
PE:-10.70
High:77.70
Open:77.30
Low:76.65
Close:77.18
52wk High:88.31
52wk Low:35.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.94
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-61.58
PE(LYR):-11.75

Loading ...

Top Cytokinetics Executive Makes Eye-Catching Move With Insider Stock Sale

TIPRANKS
·
Jul 31

Earning Preview: Cytokinetics this quarter’s revenue is expected to increase by 629.37%, and institutional views are bullish

Earnings Agent
·
Jul 31

Cytokinetics EVP, Chief Commercial Officer Andrew Callos Sells 14,000 Common Shares for $1.12 Million

Reuters
·
Jul 31

Cytokinetics Wins UK Approval, NICE Backing for Heart Disease Drug

Reuters
·
Jul 30

Cytokinetics announces MHRA authorization for Myqorzo

TIPRANKS
·
Jul 30

Cytokinetics Says UK MHRA Approves Myqorzo for Obstructive Hypertrophic Cardiomyopathy

Reuters
·
Jul 30

Cytokinetics Announces Mhra Marketing Authorisation for Myqorzo®▼ (Aficamten) and Positive Guidance from Nice for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

THOMSON REUTERS
·
Jul 30

UK's Mhra: Confidential Discount Has Been Agreed with Cytokinetics, to Make Aficamten Available to Nhs at Reduced Cost

THOMSON REUTERS
·
Jul 30

Is Cytokinetics (CYTK) Cheap Or Has Its Cardiac Growth Story Already Been Priced In?

Simply Wall St.
·
Jul 28

Top Cytokinetics Insider Makes Major Move in High-Value Stock Sale

TIPRANKS
·
Jul 28

Cytokinetics CEO Robert I. Blum Disposes of 7,500 Common Shares for $606,525

Reuters
·
Jul 28

Travelers, TransDigm, Cytokinetics, Global-e, Crescent Shock Moves

TIPRANKS
·
Jul 25

Top Cytokinetics Executive Makes Notable Insider Stock Move

TIPRANKS
·
Jul 24

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares for $282,065

Reuters
·
Jul 24

Cytokinetics Schedules Q2 Earnings Release, Conference Call

Reuters
·
Jul 24

Cytokinetics to Announce Second Quarter Results on August 6, 2026

THOMSON REUTERS
·
Jul 24

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 16

Cytokinetics CEO Robert I. Blum Disposes of 7,500 Common Shares for $615,150

Reuters
·
Jul 15